Abstract:BACKGROUND: Bioartificial liver support systems are becoming an effective therapy for hepatic failure. Bioreactors, as key devices in these systems, can provide a favorable growth and metabolic environment, mass exchange, and immunological isolation as a platform. Currently, stagnancy in bioreactor research is the main factor restricting the development of bioartificial liver support systems. DATA SOURCES: A PubMed database search of English-language literature was performed to identify relevant articles using the keywords "bioreactor", "bioartificial liver", "hepatocyte", and "liver failure". More than 40 articles related to the bioreactors of bioartificial livers were reviewed. RESULTS: Some progress has been made in the improvement of structures, functions, and modified macromolecular materials related to bioreactors in recent years. The current data on the improvement of bioreactor configurations for bioartificial livers or on the potential of the use of certain scaffold materials in bioreactors, combined with the clinical efficacy and safety evaluation of cultured hepatocytes in vitro, indicate that the AMC (Academic Medical Center) BAL bioreactor and MELS (modular extracorporeal liver support) BAL bioreactor system can partly replace the synthetic and metabolic functions of the liver in phase I clinical studies. In addition, it has been indicated that the microfluidic PDMS (polydimethylsiloxane) bioreactor, or SlideBioreactor, and the microfabricated grooved bioreactor are appropriate for hepatocyte culture, which is also promising for bioartificial livers. Similarly, modified scaffolds can promote the adhesion, growth, and function of hepatocytes, and provide reliable materials for bioreactors. CONCLUSIONS: Bioreactors, as key devices in bioartificial livers, play an important role in the therapy for liver failure both now and in the future. Bioreactor configurations are indispensable for the development of bioartificial livers used for liver failure, just as the modified scaffold materials available for bioreactors are favorable to the construction of effective bioartificial livers.

Bioartificial liver and liver transplantation: new modalities for the treatment of liver failure

Changes and perspectives of non-biological artificial liver treatment

[Current Status and Perspectives of Artificial Liver for Treatment of Acute-on-chronic Liver Failure].

Application of artificial liver support system in treatment of liver failure

[Research Advances in Diagnosis and Treatment of Liver Failure in 2016].

Cell therapy in end-stage liver disease: replace and remodel

Liver failure and the progress of Li's artificial liver system

Advances in cell sources of hepatocytes for bioartificial liver.

Liver Transplantation in Patients with Liver Failure: Twenty Years of Experience from China

Research Progress of Cell Therapy in the Preservation and Functional Repair of Donor Livers

Arouse potential stemness: Intrinsic and acquired stem cell therapeutic strategies for advanced liver diseases.

End-stage liver failure: filling the treatment gap at the intensive care unit

Stem Cell-Based Strategies: The Future Direction of Bioartificial Liver Development

The Development of a New Bioartificial Liver and Its Application in 12 Acute Liver Failure Patients

Progress in bioreactors of bioartificial livers.

Systematic Review: Extracorporeal Bio-Artificial Liver-Support System for Liver Failure

Systematic evaluation of extracorporeal bioartificial liver support system for the treatment of liver failure

Bioartificial Liver Devices: Perspectives on the State of the Art

Key Challenges to the Development of Extracorporeal Bioartificial Liver Support Systems

Bioartificial livers: a review of their design and manufacture

Acute Liver Failure and Bioartificial Liver Support